Clinical trial Recruiting at 1 site Interventional Ages 40 to 80

Catheter embolization of small knee arteries to relieve osteoarthritis pain

Official title: Percutaneous Transcatheter Genicular Embolization in Osteoarthritis

Run by Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. · NCT07361198 · Data updated 2026-11-12

This study will try using a catheter procedure to block small arteries around the knee to reduce chronic pain in adults 40–80 with knee osteoarthritis or persistent pain after knee replacement who haven't found enough relief from standard treatments.

More Osteo Arthritis Knee trials

Quick facts

Study typeInterventional
Ages40 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorMasarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Academic / other
Locations1 site (Ústí nad Labem)
StatusRecruiting
StartedFebruary 2, 2026
Main results expectedDecember 23, 2026
Study endsDecember 1, 2029
Registry record updatedFebruary 4, 2026
Trial IDNCT07361198 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 40–80 with radiographic knee osteoarthritis (Kellgren-Lawrence II–IV) or ongoing pain after total knee arthroplasty who have not had sufficient relief from medications, physical therapy, or injections and who can consent to angiographic procedures.

Probably not a fit

Patients with generalized pain syndromes (e.g., fibromyalgia), active infection, severe renal impairment, uncorrectable coagulation problems, contrast allergy, significant peripheral arterial disease, pregnancy, or those already responding to conservative care are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center pilot trial of selective genicular artery embolization performed under local anesthesia via femoral arterial access. Angiography is used to identify focal hypervascular regions (

Why it matters

Potential benefit: If successful, the procedure could reduce knee pain and improve function, potentially delaying or avoiding more invasive surgery.

How similar studies have gone: Early pilot studies and case series of genicular artery embolization have reported pain relief in some patients, but larger randomized trials and long-term outcome data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 40 to 80 years
* Clinical symptoms consistent with chronic knee pain
* Radiographically confirmed knee osteoarthritis of Kellgren-Lawrence grade II-IV or persistent knee pain following total knee arthroplasty
* Insufficient pain relief after standard conservative treatment (e.g., pharmacological therapy, physical therapy, or injections)
* Ability to understand the study procedures and provide written informed consent \_ Willingness and ability to comply with the study procedures and follow-up schedule

Exclusion Criteria:

* Active local or systemic infection
* Known coagulation disorders or ongoing anticoagulation that cannot be safely interrupted
* Significant peripheral arterial disease affecting the lower limbs
* Known allergy or contraindication to iodinated contrast agents
* Severe renal impairment
* History of fibromyalgia or other generalized chronic pain syndromes that may confound pain assessment
* Pregnancy or breastfeeding

Where it's running

  • Masarykova nemocnice v Ústí nad Labem
    Ústí nad Labem, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.